Advancing the Cardiovascular Care of the Oncology Patient

Advancing the Cardiovascular Care of the Oncology Patient

COURSE OVERVIEW/STATEMENT OF NEED

Cardiovascular disease is the second leading cause of morbidity and mortality in cancer survivors. Since an estimated 14.5 million cancer patients and survivors have significant cardiovascular risk factors, it is critical for cardiologists, oncologists, and the entire multi-professional care team to stay on the leading edge of this rapidly evolving field. Advancing the Cardiovascular Care of the Oncology Patient provides clinicians and researchers with the tools needed to improve patient care in your everyday practice.

Over the past 4 years, the American College of Cardiology has joined forces with respected experts in the field of Cardio-oncology to develop a program covering the most relevant and required content for both the novice and advancing practitioner. Join us at Advancing the Cardiovascular Care of the Oncology Patient and engage with our growing community. Participate through interactive case discussions on evidence-based treatment strategies that address pre, intra and post-chemotherapy heart health. Throughout the course, you'll have the unique opportunity to engage with expert faculty and a network of colleagues centered around ensuring your patients receive the most informed care possible.

Goal
The overall goal of this course is to provide clinically relevant, state-of-the-art, best practice strategies for the interprofessional team in the assessment, diagnosis and management of cardiovascular concerns for patients with cancer and/or those requiring survivorship care.

Learner Objectives
Coming Soon

Target Audience
The target audience is cardiovascular specialists, oncologists, internists, and all members of the multi-professional care team (including advanced practice providers, pharmacists, nurses) who are providing clinical care to the growing population of cancer patients and survivors with cardiovascular concerns.

2019 Pre-conference Educational Seminar: Pharmacologic Review of Cancer Therapy Essentials

We will kick off Friday evening with an optional, limited-seating pre-conference entitled Pharmacologic Review of Cancer Therapy Essentials: Anthracyclines, Her2+ Targeted Therapy, Immunotherapy, Tyrosine Kinase Inhibitors, Proteasome Inhibitors.

Friday, February 14, 2020
4:00 p.m. – 6:30 p.m. at Heart House

Pre-conference Registration Rate = $100

15% Discount to Pre-conference if included with course registration – ends October 24, 2019

Limited Seating 110 people – Register Early and SAVE

To Register online for the Course please click the Register button at the top of the page.

If you have any special Dietary requirements, please note that this is now captured through your online profile. To enable us to accommodate your request, please ensure that your profile is up to date. If you select the (other) option, a member of our team will be in touch to discuss your needs. If you require assistance, please contact the Resource Center at 800-253-4636, ext. 5603.

To Register by Fax or Ground Mail for the Course click here.

Please register me as: Designation   Early Before 10/24/19 Advanced 10/25/19 – 1/7/20  Regular 1/8/20 – 2/15/20
Member Physician (includes International Associate)
MD, DO, PhD $600
$700
$800
Non-member Physician
MD, DO, PhD $800
$900
$1,000
AACC/CCA Member - Includes CVT Member, FIT, Resident, Student and Emeritus
PA, RN, NP, CNS, PharmD, FIT, Resident, Student and Emeritus
$400 $500
$600
CCA Non-member
PA, RN, NP, CNS, PharmD, FIT, Resident, Student
$500
$600
$700
Industry Professional
  $900
$1,000
$1,100

Tuition
The registration tuition includes educational sessions, continental breakfasts, refreshment breaks, lunch and course materials.

Cancellations
Cancellation, substitution or transfer to another course is allowed if written notification is received four weeks before a scheduled course. A full refund minus a $250 processing fee will be given for written notifications received fewer than four weeks before the first day of the course. No refund will be given for no-shows.

ACC reserves the right to cancel the course in the unlikely event of insufficient enrollment or other unforeseen circumstances. If a course is canceled or postponed, ACC will refund registration tuition but cannot be held responsible for other costs or expenses, including cancellation/change penalties assessed by airlines, travel agencies or hotels.

TRAVEL

Location:
The course will be held at The Ritz-Carlton, 1150 22nd Street, NW, Washington, DC 20037. The telephone number is 202-835-0500.

Accommodations

Location:
The Ritz-Carlton
1150 22nd Street, NW
Washington, DC 20037

Online Reservation Link:
Click here to make your reservations online.

Reservations via telephone:
To make a reservation by phone, you can either call the hotel direct at 202-835-0500 or 800-558-9444 and identify yourself as being with the American College of Cardiology/Advancing the Cardiovascular Care of the Oncology Patient group.

Room Rates:
The ACC negotiated room rate is $249 per night plus state and local taxes (currently 14.5%) per night. The ACC room block is scheduled to be held until January 15, 2020, but may sell out prior to this date. We advise you to register for the course and reserve your lodging as soon as possible.

Thank you for your interest in submitting an abstract for Advancing the Cardiovascular Care of the Oncology Patient scheduled for February 14-16, 2020 in Washington, D.C.

Before submitting an abstract, please thoroughly review the abstract policies and procedures and submission instructions.

Submission

Click here to submit an abstract.

Deadline: All abstracts must be submitted by 11:59 p.m. EST on December 8, 2019.

General Information

  • All abstract presentations will be in English. All abstracts will be presented as poster presentations on February 14-16, 2020.
  • Investigators do not need be ACC members to participate.
  • All accepted abstract presenters must register to obtain a meeting badge. Individuals should register in the appropriate category (member, nonmember, etc.) and pay the fees appropriate for that category.
  • ACC is unable to reimburse abstract presenters for travel, hotel, or per diem expenses.
  • General Information subject to change due to circumstances beyond the ACC's control.

Disposition/Notification of Acceptance

You will be sent a notification with the status of your submission via email on December 20, 2019. If accepted, you will be directed to provide disclosure and registration information.

Withdrawals

To withdraw an abstract, email Ryan Meyer at rmeyer@acc.org and provide the title of the abstract, as well as the primary author's name. Your notification of withdrawal must be received by Friday, January 3, 2020.

EMBARGO POLICY
ACC Advancing the Cardiovascular Care of the Oncology Patient Conference 2020 abstracts are embargoed until Friday, Feb. 14, 2020, at 6:30 p.m. ET. Therefore, authors/institutions and members of the press cannot distribute or publish any information (other than the title) from the abstract while the embargo is in effect. The ACC welcomes the participation of institutions in promoting research presented at the ACC Advancing the Cardiovascular Care of the Oncology Patient Conference 2020. All promotions must abide by the embargo date and time. For questions, please contact ACC Sr. Media Relations Associate Katie Glenn, kglenn@acc.org.

Clinical Topics: Cardio-Oncology

Keywords: Cardiotoxicity